GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (STU:VG20) » Definitions » Net Change in Cash

Avinger (STU:VG20) Net Change in Cash : €-8.61 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Avinger Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Avinger's Net Change in Cash for the three months ended in Dec. 2023 was €-3.16 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was €-8.61 Mil.


Avinger Net Change in Cash Historical Data

The historical data trend for Avinger's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Net Change in Cash Chart

Avinger Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.92 9.24 -2.38 -4.62 -8.55

Avinger Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.57 -3.95 -2.99 1.50 -3.16

Avinger Net Change in Cash Calculation

Avinger's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Avinger's Net Change in Cash for the quarter that ended in Dec. 2023


Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avinger Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Avinger's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger (STU:VG20) Business Description

Traded in Other Exchanges
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Avinger (STU:VG20) Headlines

No Headlines